Tag:
CardioVascular BioTherapeutics
Latest Headlines
Latest Headlines
Data deal supports fast-track case
CardioVascular BioTherapeutics is combining its own Phase II trial data with data from another drugmaker to make its case for fast-track development of a wound-healing treatment. CVBT has licensed
